Cite

HARVARD Citation

    Chen, W. et al. (n.d.). CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas. Molecular oncology. 8 (3), pp. 704-716. [Online]. 
  
Back to record